{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:19:04Z","timestamp":1791980344326,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Joint Funds for the Innovation of Science and Technology, Fujian Province","award":["2024Y9554"],"award-info":[{"award-number":["2024Y9554"]}]},{"name":"Fujian Provincial Natural Science Foundation of China","award":["2024J0112"],"award-info":[{"award-number":["2024J0112"]}]},{"name":"Xiamen Medical College School-Hospital Joint Funding Project","award":["K2023-03"],"award-info":[{"award-number":["K2023-03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"DOI":"10.1186\/s40246-026-00973-4","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:26:21Z","timestamp":1777404381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive transcriptomics and proteome analysis to identify prognostic risk factors for MYCN non-amplified high-risk neuroblastoma"],"prefix":"10.1186","volume":"20","author":[{"given":"Shan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaobin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"4653","key":"973_CR1","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1126\/science.6719137","volume":"224","author":"GM Brodeur","year":"1984","unstructured":"Brodeur GM, Seeger RC, Schwab M, Varmus H, E.Bishop. J M Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 1984;224(4653):1121\u20134.","journal-title":"Science"},{"key":"973_CR2","doi-asserted-by":"publisher","first-page":"16078","DOI":"10.1038\/nrdp.2016.78","volume":"2","author":"KK Matthay","year":"2016","unstructured":"Matthay KK, Maris JM, Schleiermacher G, Nakagawara A,Mackall CL, Diller L, et al. Neuroblastoma Nat Rev Dis Primers. 2016;2:16078.","journal-title":"Neuroblastoma Nat Rev Dis Primers"},{"issue":"11","key":"973_CR3","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1038\/s41416-024-02666-y","volume":"130","author":"X Hu","year":"2024","unstructured":"Hu X, Zhou Y, Hill C, Cheng C, Liu X, et al. Identification of MYCN non-amplified neuroblastoma subgroups points towards molecular signatures for precision prognosis and therapy stratification. Br J Cancer. 2024;130(11):1841\u201354.","journal-title":"Br J Cancer"},{"issue":"5","key":"973_CR4","doi-asserted-by":"publisher","first-page":"6423","DOI":"10.1007\/s12035-024-04680-w","volume":"62","author":"R Sharma","year":"2025","unstructured":"Sharma R, Yadav J, Bhat SA, Musayev A,Myrzagulova S, Sharma D, et al. Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research. Mol Neurobiol. 2025;62(5):6423\u201366.","journal-title":"Mol Neurobiol"},{"key":"973_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/ijms26104722","volume":"26","author":"D Benchia","year":"2025","unstructured":"Benchia D, B\u00eec\u0103 O, D,S\u00e2rbu I,Savu B,Farca\u0219 D,Miron I, et al. Targeting Pathways in Neuroblastoma: Advances in Treatment Strategies and Clinical Outcomes. Int J Mol Sci. 2025;26:10.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"973_CR6","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1093\/neuonc\/noae152","volume":"26","author":"L Sainero-Alcolado","year":"2024","unstructured":"Sainero-Alcolado L,Sj\u00f6berg, Bexelius T, Santopolo G, Yuan Y. Arsenian-Henriksson M Defining neuroblastoma: From origin to precision medicine. Neuro Oncol. 2024;26(12):2174\u201392.","journal-title":"Neuro Oncol"},{"issue":"8","key":"973_CR7","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1158\/1078-0432.CCR-22-3032","volume":"29","author":"NNA Pinto","year":"2023","unstructured":"Pinto NNA, Ding X,Zhang FF, Hibbitts E, Kennedy R, et al. Impact of Genomic and Clinical Factors on Outcome of Children\u2009\u2265\u200918 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children\u2019s Oncology Group (COG) Report. Clin Cancer Res. 2023;29(8):1546\u201356.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"973_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/biom12010018","volume":"12","author":"M Ohira","year":"2021","unstructured":"Ohira M, Nakamura Y, Takimoto T, Nakazawa A,Hishiki T, Matsumoto K et al. Retrospective Analysis of INRG Clinical and Genomic Factors for 605 Neuroblastomas in Japan: A Report from the Japan Children\u2019s Cancer Group Neuroblastoma Committee (JCCG-JNBSG). Biomolecules. 2021; 12(1).18.","journal-title":"Biomolecules"},{"issue":"1","key":"973_CR9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s12672-024-01318-0","volume":"15","author":"JX Wang","year":"2024","unstructured":"Wang JX, Zhang HY, Yan ZJ, Cao Z Y,Shao JBZL. Identification and validation of a novel five-gene signature in high-risk MYCN-not-amplified neuroblastoma. Discov Oncol. 2024;15(1):456.","journal-title":"Discov Oncol"},{"issue":"21","key":"973_CR10","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.1158\/1078-0432.CCR-08-1249","volume":"14","author":"S Yagyu","year":"2008","unstructured":"Yagyu S, Gotoh T, Iehara T,Miyachi M, Katsumi Y, Tsubai-Shimizu S, et al. Circulating methylated-DCR2 gene in serum as an indicator of prognosis and therapeutic efficacy in patients with MYCN nonamplified neuroblastoma. Clin Cancer Res. 2008;14(21):7011\u20139.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"973_CR11","doi-asserted-by":"publisher","first-page":"167120","DOI":"10.1016\/j.bbadis.2024.167120","volume":"1870","author":"S Chakraborty","year":"2024","unstructured":"Chakraborty S, Sharma G, Karmakar S, Banerjee S. Multi-OMICS approaches in cancer biology: New era in cancer therapy. Biochim Biophys Acta Mol Basis Dis. 2024;1870(5):167120.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"973_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/ijms25063563","volume":"25","author":"C Donisi","year":"2024","unstructured":"Donisi C, Pretta A, Pusceddu V, Ziranu P, Lai E, Puzzoni M, et al. Immunotherapy and Cancer: The Multi-Omics Perspective. Int J Mol Sci. 2024;25:6.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"973_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1200\/JCO.2008.16.6876","volume":"27","author":"T Monclair","year":"2009","unstructured":"Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol. 2009;27(2):298\u2013303.","journal-title":"J Clin Oncol"},{"issue":"D1","key":"973_CR14","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol Y, Csordas A, Bai J, Bernal-Llinares M, Hewapathirana S, Kundu DJ, et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019;47(D1):D442\u201350.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"973_CR15","doi-asserted-by":"publisher","first-page":"D608","DOI":"10.1093\/nar\/gkx1089","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Marcu A, Guo AC, Liang K, V\u00e1zquez-Fresno R, et al. HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res. 2018;46(D1):D608\u201317.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"973_CR16","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk D, Franceschini A,Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(Database issue):D447\u201352.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"973_CR17","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1158\/2159-8290.CD-16-0861","volume":"8","author":"P Rajbhandari","year":"2018","unstructured":"Rajbhandari P, Lopez G,Capdevila C, Salvatori B, Yu J, Rodriguez-Barrueco R, et al. Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma. Cancer Discov. 2018;8(5):582\u201399.","journal-title":"Cancer Discov"},{"issue":"4","key":"973_CR18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3892\/ol.2022.13256","volume":"23","author":"Y Koike","year":"2022","unstructured":"Koike Y, Yin C,Sato Y, Nagano Y,Yamamoto A, Kitajima T, et al. TPX2 is a prognostic marker and promotes cell proliferation in neuroblastoma. Oncol Lett. 2022;23(4):136.","journal-title":"Oncol Lett"},{"issue":"5","key":"973_CR19","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1158\/0008-5472.CAN-05-0854","volume":"66","author":"XX Tang","year":"2006","unstructured":"Tang XX, Zhao H, Kung B, Kim DY, Hicks SL, Cohn SL, et al. The MYCN enigma: significance of MYCN expression in neuroblastoma. Cancer Res. 2006;66(5):2826\u201333.","journal-title":"Cancer Res"},{"issue":"2","key":"973_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1177\/10935266231151316","volume":"26","author":"M Zhao","year":"2023","unstructured":"Zhao M, Gu W, Liu F, Yu L, Shu Y, Liu L, et al. Prominent Staining of MYCN Immunohistochemistry Predicts a Poor Prognosis in MYCN Non-Amplified Neuroblastoma. Pediatr Dev Pathol. 2023;26(2):124\u201332.","journal-title":"Pediatr Dev Pathol"},{"issue":"3","key":"973_CR21","doi-asserted-by":"publisher","first-page":"a041548","DOI":"10.1101\/cshperspect.a041548","volume":"15","author":"AM Winkelkotte","year":"2025","unstructured":"Winkelkotte AM, Al-Shami K, Chaves-Filho AB, Vogel FC. A Interactions of Fatty Acid and Cholesterol Metabolism with Cellular Stress Response Pathways in Cancer. Cold Spring Harb Perspect Med. 2025;15(3):a041548.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"5","key":"973_CR22","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.tcb.2024.09.006","volume":"35","author":"V Varadharaj","year":"2025","unstructured":"Varadharaj V, Petersen W, Batra S, K.Ponnusamy. M P Sugar symphony: glycosylation in cancer metabolism and stemness. Trends Cell Biol. 2025;35(5):412\u201325.","journal-title":"Trends Cell Biol"},{"issue":"17","key":"973_CR23","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1158\/0008-5472.CAN-20-2153","volume":"81","author":"NM Anderson","year":"2021","unstructured":"Anderson NM, Qin X,Finan JM, Lam A, Missiaen R, et al. Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma. Cancer Res. 2021;81(17):4417\u201330.","journal-title":"Cancer Res"},{"key":"973_CR24","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.isci.2019.10.020","volume":"21","author":"G Oliynyk","year":"2019","unstructured":"Oliynyk G, Ruiz-P\u00e9rez MV, Sainero-Alcolado L, Dzieran J, Zirath H, Gallart-Ayala H, et al. MYCN-enhanced Oxidative and Glycolytic Metabolism Reveals Vulnerabilities for Targeting Neuroblastoma. iScience. 2019;21:188\u2013204.","journal-title":"iScience"},{"issue":"22","key":"973_CR25","doi-asserted-by":"publisher","first-page":"e165703","DOI":"10.1172\/jci.insight.165703","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu Y, Zhang J, Cao F, Dong X, Li J, Cao Y, et al. N6-methyladenosine-mediated overexpression of long noncoding RNA ADAMTS9-AS2 triggers neuroblastoma differentiation via regulating LIN28B\/let-7\/MYCN signaling. JCI Insight. 2023;8(22):e165703.","journal-title":"JCI Insight"},{"issue":"22","key":"973_CR26","doi-asserted-by":"publisher","first-page":"13850","DOI":"10.3390\/ijms232213740","volume":"23","author":"TPJ Luo","year":"2022","unstructured":"Luo TPJ, Li Q, Zhang Y, Huang Y, Xu L, et al. GDPD5 Related to Lipid Metabolism Is a Potential Prognostic Biomarker in Neuroblastoma. Int J Mol Sci. 2022;23(22):13850.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"973_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10555-020-09946-y","volume":"40","author":"IS Fetahu","year":"2021","unstructured":"Fetahu IS. Neuroblastoma and the epigenome. Cancer Metastasis Rev. 2021;40(1):173\u201389.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"973_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10555-020-09843-4","volume":"39","author":"GP Tonini","year":"2020","unstructured":"Tonini GP. .Capasso M Genetic predisposition and chromosome instability in neuroblastoma. Cancer Metastasis Rev. 2020;39(1):275\u201385.","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"973_CR29","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41588-023-01332-y","volume":"55","author":"V K\u00f6rber","year":"2023","unstructured":"K\u00f6rber V, Stainczyk SA, Kurilov R,Henrich K O,Hero B, Brors B, et al. Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome. Nat Genet. 2023;55(4):619\u201330.","journal-title":"Nat Genet"},{"key":"973_CR30","unstructured":"Durinck K. Irwin M S DNA repair and replicative stress addiction in neuroblastoma. EJC Paediatric Oncology."},{"issue":"4","key":"973_CR31","doi-asserted-by":"publisher","first-page":"115537","DOI":"10.1016\/j.celrep.2025.115537","volume":"44","author":"MN Hayes","year":"2025","unstructured":"Hayes MN, Cohen-Gogo S, Kee L, Xiong X,Weiss A, Layeghifard M, et al. DNA damage response deficiency enhances neuroblastoma progression and sensitivity to combination PARP and ATR inhibition. Cell Rep. 2025;44(4):115537.","journal-title":"Cell Rep"},{"issue":"1","key":"973_CR32","first-page":"678","volume":"18","author":"L Yuan","year":"2019","unstructured":"Yuan L, Liu C, Wan Y, Yan H, Li T. Effect of HDAC2\/Inpp5f on neuropathic pain and cognitive function through regulating PI3K\/Akt\/GSK-3\u03b2 signal pathway in rats with neuropathic pain. Exp Ther Med. 2019;18(1):678\u201384.","journal-title":"Exp Ther Med"},{"issue":"1","key":"973_CR33","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1186\/s12967-024-05634-5","volume":"22","author":"M Suman","year":"2024","unstructured":"Suman M, L\u00f6fgren M,Fransson S, Yousuf J I,Svensson J, Djos A, et al. Altered methylation of imprinted genes in neuroblastoma: implications for prognostic refinement. J Transl Med. 2024;22(1):808.","journal-title":"J Transl Med"},{"issue":"1","key":"973_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13046-021-02216-x","volume":"41","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Lin J, Yan Y,Meng S, Liao H, Chen R, et al. INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma. J Exp Clin Cancer Res. 2022;41(1):13.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"973_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3892\/ijmm.2017.2988","volume":"40","author":"HA Kim","year":"2017","unstructured":"Kim HA, Kwon NS, Baek KJ, Kim DS. H Y Leucine-rich glioma inactivated 3: Integrative analyses support its role in the cytokine network. Int J Mol Med. 2017;40(1):251\u20139.","journal-title":"Int J Mol Med"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-026-00973-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-026-00973-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-026-00973-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:02:27Z","timestamp":1781542947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40246-026-00973-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["973"],"URL":"https:\/\/doi.org\/10.1186\/s40246-026-00973-4","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}